Prelude Therapeutics Inc
Prelude Therapeutics Inc (PRLD) Implied Volatility Current
PRLD implied volatility is 65%. IV Rank is 1%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking PRLD implied volatility helps you identify when options premiums on Prelude Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Prelude Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when PRLD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Prelude Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PRLD, tracking metrics like PRLD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PRLD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors.
The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PRLD implied volatility sits today versus where it has been. Our scanner ranks Prelude Therapeutics Inc implied volatility against its historical range, surfaces extremes in PRLD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Prelude Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 17, 2026
Trade options with IV on your side
Track PRLD IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→